Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
127,672,444
-
Number of holders
-
132
-
Total 13F shares, excl. options
-
43,885,493
-
Shares change
-
+2,565,781
-
Total reported value, excl. options
-
$1,343,772,430
-
Value change
-
+$85,692,286
-
Put/Call ratio
-
92%
-
Number of buys
-
73
-
Number of sells
-
60
-
Price
-
$30.62
Institutional Holders of Apellis Pharmaceuticals, Inc. - Common Stock (APLS) as of Q4 2019
As of 31 Dec 2019 Apellis Pharmaceuticals, Inc. - Common Stock (APLS) had 132 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 43,885,493 shares of stock of the company.
Largest 10 holders included BlackRock Inc., HILLHOUSE CAPITAL ADVISORS, LTD., WELLINGTON MANAGEMENT GROUP LLP, Cormorant Asset Management, LP, VANGUARD GROUP INC, STATE STREET CORP, VICTORY CAPITAL MANAGEMENT INC, FIL Ltd, BARCLAYS PLC, and JENNISON ASSOCIATES LLC.
This table shows 132 institutional shareholders of the security as of 31 Dec 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.